Narrow Results

Lung cancer is the most deadly malignancy in the US. Chemoprevention is potentially a complementary approach to smoking cessation for lung cancer control. Recently, we reported that a commercially available form of kava extract significantly inhibits 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and benzo(a)pyrene (BaP)-induced lung tumorigenesis in A/J mice at a dose of 10 mg per gram diet. In the present study, we examined the dose-dependent lung tumor inhibitory activities of kava and investigated potential active constituent(s). Mice treated with carcinogen alone contained 12.1±5.8 lung adenomas per mouse 22 weeks after final carcinogen administration. Mice that were fed diets containing kava at dosages of 1.25, 2.5, 5, and 10 mg/g of diet had 8.4±3.5, 6.6±3.5, 4.3±2.4, and 3.8±2.3 lung adenomas per mouse, respectively. This corresponds to a reduction of 31%, 46%, 65% and 69% in tumor multiplicity, which were all statistically significant (p < 0.05). Analyses of lung adenoma tissues derived from kava-treated animals revealed that kava significantly inhibited adenoma cell proliferation while it had no detectable effect on cell death, indicating that kava primarily suppressed lung tumorigenesis in A/J mice via inhibition of cell proliferation. Flavokawains A, B, and C, three chalcone-based components from kava, demonstrated greatly reduced chemopreventive efficacies even at concentrations much higher than their natural abundance, suggesting that they alone were unlikely to be responsible for kava's chemopreventive activity. Kava at all dosages and treatment regimens did not induce detectable adverse effects, particularly with respect to liver. Specifically, kava treatment showed no effect on liver integrity indicator enzymes or liver weight, indicating that kava may be potentially safe for long-term chemopreventive application.

AUSTRALIA – World-Class Cancer Center to be Built in Parkville.

AUSTRALIA – Cure Found for Devastating Muscle Disease.

AUSTRALIA – HIV Test to Help Monitor Sufferers.

AUSTRALIA – Radium Weed Weeds Out Sun Spots, Skin Cancer.

AUSTRALIA – Kava Safe and Effective in Reducing Anxiety.

CHINA – CAS Develops New Salt-tolerant Wheat.

CHINA – Search for Passengers on Flights with Flu Case.

HONG KONG – Hong Kong Confirms Asia's 1st Swine Flu Case.

INDIA – Indian Healthcare Market to Grow Despite Slowdown.

INDIA – WHO Lifts Vaccine Embargo on India.

JAPAN – Scientists Create World's First Transgenic Monkeys.

JAPAN – Japan Swine Flu Cases Surge.

NEW ZEALAND – New Frontiers in Gene Behavior.

NEW ZEALAND – Innovative Pet Food Research Consortium Launched.

SINGAPORE – 50 Receive Healthcare Humanity Awards.

SINGAPORE – No-Go for Swine Flu Parties.

SINGAPORE – Asia's First Combined Heart and Liver Transplant.

SINGAPORE – Singapore to Host Conference on Tobacco or Health.

SINGAPORE – Diabetes Hits Asia's Youth.

SOUTH KOREA – $14.6 mn for Fight Against New Flu.

TAIWAN – Flu Vaccine to be Available by End of Year.

TAIWAN – Mutation in Gene allows Cancer to Spread.

TAIWAN – Scientists Find Ways to Improve Cancer Drugs.

TAIWAN – Team Makes Discovery in Search for New Antibiotic.

TAIWAN – Taiwan Tags Sixteen Countries with Yellow Travel Alert Over Flu.

TAIWAN – Team Makes Breakthrough in Therapy for Childhood Cancer.

THAILAND – Thailand Tries to Become Starch-Production Hub.

THAILAND – Thailand and Taiwan to Begin Biotech Cooperation Plan.

VIETNAM – US gives Vietnam Protective Bird Flu Equipment.

OTHER REGIONS — UNITED STATES – Over 52's May Be Better Protected.